These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 22476347)

  • 1. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
    Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
    Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.
    Li H; Zhang B; Liu Y; Yin C
    Med Oncol; 2014 Sep; 31(9):162. PubMed ID: 25119502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
    Zheng J; Dai Y; Yang Z; Yang L; Peng Z; Meng R; Xiong Y; He J
    Oncol Rep; 2016 Jan; 35(1):530-7. PubMed ID: 26531778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
    Zhang X; Diaz MR; Yee D
    Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBP50 suppresses the proliferation of MCF-7 human breast cancer cells via promoting Beclin-1/p62-mediated lysosomal degradation of c-Myc.
    Liu H; Zhao WL; Wang JP; Xin BM; Shao RG
    Acta Pharmacol Sin; 2018 Aug; 39(8):1347-1358. PubMed ID: 29283175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of RasGRP3 in the formation and progression of human breast cancer.
    Nagy Z; Kovács I; Török M; Tóth D; Vereb G; Buzás K; Juhász I; Blumberg PM; Bíró T; Czifra G
    Mol Cancer; 2014 Apr; 13():96. PubMed ID: 24779681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
    Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
    Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezrin-Radixin-Moesin Binding Phosphoprotein 50 (EBP50) Suppresses the Metastasis of Breast Cancer and HeLa Cells by Inhibiting Matrix Metalloproteinase-2 Activity.
    Wang L; Qi Y; Xiong Y; Peng Z; Ma Q; Zhang Y; Song J; Zheng J
    Anticancer Res; 2017 Aug; 37(8):4353-4360. PubMed ID: 28739728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBP50 promotes focal adhesion turnover and vascular smooth muscle cells migration.
    Song GJ; Leslie KL; Barrick S; Bougoin S; Taboas JM; Bisello A
    J Mol Cell Cardiol; 2012 Dec; 53(6):809-19. PubMed ID: 22974528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodic Mechanical Stress Activates PKCδ-Dependent EGFR Mitogenic Signals in Rat Chondrocytes via PI3K-Akt and ERK1/2.
    He P; Shen N; Gao G; Jiang X; Sun H; Zhou D; Xu N; Nong L; Ren K
    Cell Physiol Biochem; 2016; 39(4):1281-94. PubMed ID: 27606614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes.
    Nunes M; Shi C; Greenberger LM
    Mol Cancer Ther; 2004 Jan; 3(1):21-7. PubMed ID: 14749472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of epidermal growth factor receptor (EGFR)-signaling versus cellular acidosis via Na+/H+ exchanger1(NHE1)-inhibition in troglitazone-induced growth arrest of breast cancer-derived cells MCF-7.
    Friday E; Oliver R; Welbourne T; Turturro F
    Cell Physiol Biochem; 2007; 20(6):751-62. PubMed ID: 17982257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
    Sah JF; Eckert RL; Chandraratna RA; Rorke EA
    J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells.
    Nunes-Xavier CE; Elson A; Pulido R
    J Biol Chem; 2012 Jan; 287(5):3433-44. PubMed ID: 22117074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
    Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
    J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface protein C23 affects EGF-EGFR induced activation of ERK and PI3K-AKT pathways.
    Lv S; Dai C; Liu Y; Sun B; Shi R; Han M; Bian R; Wang R
    J Mol Neurosci; 2015 Feb; 55(2):519-24. PubMed ID: 25015231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
    Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
    Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells.
    Kavarthapu R; Dufau ML
    Oncotarget; 2016 Oct; 7(40):65602-65613. PubMed ID: 27564112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells.
    Hsieh CY; Tsai PC; Tseng CH; Chen YL; Chang LS; Lin SR
    Toxicol In Vitro; 2013 Feb; 27(1):1-10. PubMed ID: 23064031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.